Makary’s Expert Panel Sparks Regulatory Action For Menopause Hormonal Therapy

FDA Commissioner Martin Makary announced changes to hormone replacement therapy labeling on Nov. 10. (Sarah Karlin-Smith)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from US FDA